DCF — NATIONAL JEWISH HEALTH
Enterprise Value: $-133.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-133.0M
Enterprise Value
$-44.5M
PV of Cash Flows
$-88.5M
PV of Terminal Value
$-142.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $154.9M | $-7.0M | -5.0% | $-13.5M | $-12.3M |
| Year 2 | $159.6M | $-5.6M | -4.0% | $-12.3M | $-10.2M |
| Year 3 | $164.4M | $-4.1M | -3.0% | $-11.1M | $-8.3M |
| Year 4 | $169.3M | $-3.4M | -2.0% | $-10.6M | $-7.2M |
| Year 5 | $174.4M | $-3.1M | -2.0% | $-10.4M | $-6.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-133.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$150.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5